of blastomycosis that "most often presented as disseminated infection involving multiple organs" [2] . CNS involvement occurs in approximately 5%-10% of patients with progressive disseminated histoplasmosis [5] , 5% of patients with systemic blastomycosis [6] , and 3.5% of patients with coccidioidomycosis [7] . Using the TRANSNET numbers, the highest estimates would thus be 5 cases of CNS histoplasmosis and <1 case each of CNS blastomycosis and coccidioidomycosis. For these reasons, we believe that it is both inaccurate and misleading to infer the incidence of fungal CNS involvement among SOT patients using the TRANS-NET study data [2] .
We would also like to comment on the detection of fungi in cerebrospinal fluid (CSF). The sensitivity of CSF culture in detecting fungi, with the exception of Cryptococcus neoformans, is generally low. In fact, among SOT recipients, Cryptococcus culture was positive in 75%-93% of cases, whereas the antigen was detected in all [8] . By contrast, for Histoplasma capsulatum the sensitivity of CSF culture in nontransplant patients has been reported to be 27%-65% [9] , for Aspergillus 31% [10] , and for Coccidioides species 20%-38% [11] . Indirect non-culture-based methods may increase the likelihood of diagnosis in cerebral fungal infections. Aspergillus galactomannan antigen (GM) seems to be a useful diagnostic method for CNS aspergillosis in both immunocompetent and immunocompromised hosts, with an overall sensitivity of 87% [10] . Although a threshold value of CSF galactomannan has not yet been established for the diagnosis of CNS aspergillosis, high index values have been repeatedly reported [10] . Interestingly, in a patient with Aspergillus meningitis who underwent 9 serial lumbar punctures, GM was detected in the CSF 45 days before a single culture became positive [12] . Therefore, we suggest that in Table 5 of the article by Wright and Fishman, CSF GM should be added to nonculture methods for use in SOT recipients with CNS syndromes. In patients living in or who have traveled in endemic areas, a Histoplasma antigen assay that can be performed in CSF as well as urine and serum should also be considered for the diagnosis of cerebral histoplasmosis [5, 9] . Finally, it should be noted that both GM and Histoplasma antigen test may cross-react with other fungi, which emphasizes the need to obtain additional laboratory results that must always correlate with a patient's clinical, radiological, and epidemiological features.
Notes

